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1. Introduction
  Brucellosis is a widespread zoonotic infectious disease 
that is acquired by humans primarily through contact with 
infected abortion-related animal tissues and contaminated 
dairy products. It can have diverse clinical manifestations 
with symptoms that overlap with other diseases[1-3]. Owing 
to the fact that bacteriological methods are not sensitive 
enough for brocellusis detection[4,5], serological tests are 
often the preferred method for diagnosis of Brucellosis 
in both humans and animals[6]. Since the available 
serological tests detect circulating antibodies to bacterial 
lipopolysaccharide, these tests suffer from extensive cross 
reaction with other Gram-negative bacteria; therefore, 
interest in finding alternative and more specific bacterial 
antigen to detect brucellosis is on the rise[7-10].
  Several proteins from Brucella melitensis (B. melitensis) 
were found to induce an antibody response in infected 
animals and humans[11-13]. It was recently reported that 
VirB12 protein, a surface-localized protein of Brucella 
spp. elicit antibody responses in both experimentally and 
naturally infected animals[2,14]. The aim of this study was 
cloning of virB12 gene in pET28a expression vector for 
production of recombinant protein to be used as antigenic 
component for future serological test development. 
2. Materials and methods
2.1. Bacterial strains, plasmids
  B. melitensis 16M strain was procured from Pasteur 
institute of Iran. Escherichia coli (E. coli) strains DH5毩 
and BL21 (DE3) were received from Novagene Co., Cloning 
vector pJET1.2 and expression vector pET28a were obtained 
from Fermentas and Invitrogen Co., respectively.
2.2. Culture of bacteria
  B. melitensis was cultured in Brucella broth and E. coli 
was grown in Broth and agar Luria-Bertani medium. When 
antibiotic selection was necessary, the above media were 
supplemented with appropriate concentrations of antibiotic.
2.3. Genomic DNA extraction
  Genomic DNA of B. melitensis 16M strain was extracted by 
Bioneer AccuPrep® Genomic DNA Extraction kit. Quality 
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and purity of the extracted DNA were assessed using agarose 
gel electrophoresis and spectrophotometerically.
2.4. Primer design
  A pair of oligonucleotide was designed based on the 
virB12 gene sequence of B. melitensis 16M strain obtained 
from Gene Bank (Accession no. AF226278) with BamHI and 
HindIII restriction site at the 5´ end of the forward and 
reverse primers, respectively (Table 1). 
Table1
Primers designed for amplification of the virB12 gene of B. melitensis.
virB12 Primer
Forward virB12 AGTGGATCCATGCGCACATTGGTTATGGTCGC
Reverse virB12 CACAAGCTTGATATCCACGCGCCTGTTCAGG
The attached restriction enzyme sites are underlined.
2.5. PCR amplification
  The PCR reaction mixture included 2 毺L of bacterial 
genomic DNA (containing 100 ng), 150 nM dNTPs, and 1× 
PCR buffer (containing of MgCl2), 1.25 units of PrimSTAR® HS 
DNA polymerase and 40 picomoles each of the forward and 
reverse primers in 50 毺L final volume. PCR amplification 
was performed by the following parameters: denaturing at
94 曟 for 40 s, annealing at 58 曟 for 30 s and extension at 
72 曟 for 30 s in an Eppendorf master gradient thermocycler. 
PCR product was electrophoresed on 1.5% (w/v) agarose gel, 
stained with ethidium bromide and visualized under UV 
transilluminator. 
2.6. Gene cloning
  DNA band was sliced under long wave UV and recovered 
by Bioneer AccuPrep®Gel Purification Kit. Recovered DNA 
was ligated into pJET1.2 cloning vector at 22 曟 for 1 h 
with T4 DNA ligase (Fermentas Co.). The ligation product 
was transformed into E. coli DH5毩 strain competent cells 
and dispersed onto LB agar plates containing 100 毺g/mL 
ampicillin.
  After 16-18 h incubation at 37 曟, colonies on the agar 
plate that contained recombinant plasmids were detected. 
For confirmation, PCR amplifications were performed 
on these colonies using primers specific for virB12 gene 
and pJET vector and colonies containing the recombinant 
plasmid were selected. Recombinant plasmid was extracted 
by Bioneer AccuPrep® Plasmid Extraction Kit and digested 
by BamHI and HindIII restriction enzymes (Fermentas 
Co.). Following electrophoresis, the DNA digested bands 
were purified by Bioneer AccuPrep®Gel Purification Kit. 
Fragments of BamHI and HindIII digestes were subcloned in 
HindIII and BamHI digested pET28a (+) expression vector and 
transformed into E. coli DH5毩 competent cells and spread 
onto LB agar plates containing 30 毺g/mL kanamycin. Then, 
the recombinant plasmid pET28a-virB12 was confirmed by 
PCR, restriction enzymes digestion and sequencing which 
was performed by a commercial company using universal 
forward and reverse T7 promoter and terminator primers 
(TAG Copenhage A/S Symbion, Denmark).
3. Results
   Brucella virB12 gene was amplified from genomic DNA of 
B. melitensis 16M strain. The PCR products analyzed on 1.5 
% (w/v) agarose gel displayed a single band with the correct 
size (513 bp) pertaining to the amplification of the virB12 
gene (Figure 1).
  The PCR product was cloned in pJET1.2 plasmid. Colonies 
containing the pJET–virB12 recombinant plasmid were 
confirmed by PCR using VirB12 gene and pJET 1.2 primers.
  Recombinant plasmid pJET-virB12 was successfully 
digested by BamHI and Hind III restriction enzymes. The 
digested band (virB12 gene) was extracted and subcloned 
into pET28a expression vector. Presence of the inserted 
gene was confirmed by PCR method, using primers designed 
according to the sequence of the pET28a and virB12 gene 
and digestion of pET28a-virB12 recombinant plasmid by 
BamHI and HindIII (Figure 2). Negative control was pET28a 
vector alone which displayed a lower molecular weight band 
relative to the recombinant plasmid. Finally, the integrity 
and orientation of virB12 in construct were confirmed by 
DNA sequencing.
  Results show a 513 bp fragment corresponding to the 
B. melitensis virB12 gene was successfully cloned and 
transformed to the bacterial expression vector pET28a. 
500 bp
1                            2                        3
Figure 1. Electrophoresis of the amplified virB12 gene on 1.5% (w/
v) agarose gel. Lane 1: 100 bp Plus DNA ladder. Lane 2, 3: Single 
expected band of virB12 gene (approximately 513 bp).
500 bp
1                   2                  3                  4
Figure 2. Analysis of enzymatic digestion of recombinant plasmid 
on 1.5% (w/v) agarose gel. Lane 1: DNA ladder. Lane 2: virB12- 
pET28a recombinant plasmid. Lane 3: Mono digestion of virB12-
pET28a recombinant plasmid with BamHI. Lane 4: Double digestion 
of virB12-pET28a recombinant plasmid with BamHI and HindIII. 
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4. Discussion
  Brucellosis is an infectious disease that is endemic in most 
developing countries[15,16]. Rapid and accurate diagnosis of 
Brucellosis has an important role in effective treatment of 
patients and improvement of public hygiene. The routine 
serological tests that are often used are based on detection 
of anti-lipopolysaccharide antibodies. In these serological 
tests, cross reaction occur between Brucella and many other 
Gram negative bacteria[7].
  Elucidation of an antigenic component for diagnosis and 
vaccination of brucellosis infection serves as a valuable tool. 
There are several studies on different proteins of Brucella as 
antigenic component including the OMP 31 kDa, 28 kDa and 
26 kDa periplasmic proteins from B. melitensis[4,9,13].
The proteins that are located on the surface of bacteria have 
traditionally been used as useful antigens for diagnostic and 
vaccine component. For this reason, in the present study, 
cloning of the virB12 gene of Brucella that is located on 
bacterial surface was designed. 
  Previous study indicated that natural hosts infected with 
Brucella produce an antibody response to the protein 
encoded by the virB12 gene[2]. VirB12 protein is a part of 
the type IV secretion system that is encoded by the virB 
locus and is located on the surface of Brucella. Brucella 
cell surface proteins have shown to elicit an immune 
response related to the protection of the host which can also 
potentially be used for diagnostic purpose[2,14].
  In this study, the virB12 gene is cloned using DH5毩 E. coli 
as a host which doesn’t contain the T7 RNA polymerase and 
the expression vector pET28a was used that is a powerful 
system for cloning and expression of recombinant proteins 
in E. coli. The nucleotide sequence of virB12 gene cloned 
in this study was consistent with the sequence of virB12 
gene as published in the GeneBank. Cloning site in the 
pET28a also contained His Tag sequences for detection and 
purification.
  In conclusion, we were able to clone the virB12 gene of 
B. melitensis in expression vector for protein expression in 
order to be used in future study as antigenic component.
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